Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Pancreas graft thrombosis is one of the commonest non-immunological causes for early graft loss after transplantation. This case report describes a patient who developed graft thrombosis after intravenous immunoglobulin administration to treat acute parvovirus B19 infection. The potential role of hypercoagulability in graft thrombosis and the implications for immunoglobulin therapy in transplant patients with hypercoagulable states is discussed.

Original publication

DOI

10.1111/j.1399-3062.2009.00419.x

Type

Journal article

Journal

Transpl Infect Dis

Publication Date

10/2009

Volume

11

Pages

463 - 466

Keywords

Adult, Blood Coagulation, Female, Humans, Immunoglobulins, Intravenous, Immunologic Factors, Pancreas Transplantation, Parvoviridae Infections, Parvovirus B19, Human, Thrombosis, Transplantation, Homologous